ANRO
Price
$2.30
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
63.62M
44 days until earnings call
XTLB
Price
$1.32
Change
+$0.12 (+10.00%)
Updated
Jul 3 closing price
Capitalization
9.73M
Interact to see
Advertisement

ANRO vs XTLB

Header iconANRO vs XTLB Comparison
Open Charts ANRO vs XTLBBanner chart's image
Alto Neuroscience
Price$2.30
Change-$0.00 (-0.00%)
Volume$967
Capitalization63.62M
XTL Biopharmaceuticals
Price$1.32
Change+$0.12 (+10.00%)
Volume$43.81K
Capitalization9.73M
ANRO vs XTLB Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. XTLB commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and XTLB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ANRO: $2.35 vs. XTLB: $1.32)
Brand notoriety: ANRO and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 29% vs. XTLB: 108%
Market capitalization -- ANRO: $63.62M vs. XTLB: $9.73M
ANRO [@Biotechnology] is valued at $63.62M. XTLB’s [@Biotechnology] market capitalization is $9.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANRO and XTLB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while XTLB’s TA Score has 6 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 5 bearish.
  • XTLB’s TA Score: 6 bullish, 0 bearish.
According to our system of comparison, XTLB is a better buy in the short-term than ANRO.

Price Growth

ANRO (@Biotechnology) experienced а +2.17% price change this week, while XTLB (@Biotechnology) price change was +11.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ANRO is expected to report earnings on Aug 19, 2025.

XTLB is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANRO($63.6M) has a higher market cap than XTLB($9.73M). XTLB YTD gains are higher at: -34.841 vs. ANRO (-44.444). XTLB has higher annual earnings (EBITDA): 630K vs. ANRO (-60.98M). ANRO has more cash in the bank: 161M vs. XTLB (133K). ANRO (0) and XTLB (0) have equivalent revenues.
ANROXTLBANRO / XTLB
Capitalization63.6M9.73M654%
EBITDA-60.98M630K-9,679%
Gain YTD-44.444-34.841128%
P/E RatioN/AN/A-
Revenue00-
Total Cash161M133K121,053%
Total Debt26.4MN/A-
FUNDAMENTALS RATINGS
XTLB: Fundamental Ratings
XTLB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANROXTLB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APAAF0.120.02
+26.32%
APPIA RARE EARTHS & URANIUM CORP.
MRSKF21.43N/A
N/A
DMG Mori Co Ltd
WTBFB293.39N/A
N/A
W.T.B. Financial Corp.
BQCNF110.00N/A
N/A
Banque Cantonale Vaudoise
SDIIF0.66N/A
N/A
Scientific Digital Imaging PLC

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+2.17%
NUVL - ANRO
30%
Poorly correlated
-0.02%
XTLB - ANRO
26%
Poorly correlated
+10.00%
RLAY - ANRO
26%
Poorly correlated
N/A
NTLA - ANRO
26%
Poorly correlated
+0.09%
BEAM - ANRO
25%
Poorly correlated
+0.65%
More

XTLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, XTLB has been loosely correlated with SER. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XTLB jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTLB
1D Price
Change %
XTLB100%
+10.00%
SER - XTLB
59%
Loosely correlated
-3.26%
UNCY - XTLB
28%
Poorly correlated
-0.86%
BCLI - XTLB
27%
Poorly correlated
-0.85%
ADTX - XTLB
27%
Poorly correlated
-1.60%
ANRO - XTLB
26%
Poorly correlated
+2.17%
More